EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Substrate selectivity as a paradigm shift in mTORC1 signaling

Jiyoung Pan, Stephanie A Fernandes, Riko Hatakeyama, Constantinos Demetriades

Current Opinion in Cell Biology · 2026-08 · 101 · 102664

DOI: 10.1016/j.ceb.2026.102664 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Opinion in Cell Biology, 2026-08. Verfasst von Jiyoung Pan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck Institute for Biology of Ageing (MPI-AGE), 50931 Cologne, Germany. Hauptthemen laut MEDLINE: Signal Transduction, Mechanistic Target of Rapamycin Complex 1, Multiprotein Complexes, TOR Serine-Threonine Kinases. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tenovus, H2020 European Research Council, Max Planck Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

mTORC1 is a central regulator of cell growth and metabolism, classically viewed as a binary switch that promotes anabolic programs while suppressing catabolic pathways. Recent work advances this simplified model by revealing that mTORC1 signaling is highly substrate-specific, with distinct classes of substrates differentially regulated according to their modes of recruitment and subcellular localization. In this review, we discuss emerging evidence demonstrating that mTORC1 activity and its lysosomal localization can be functionally uncoupled, enabling selective phosphorylation of lysosomal versus non-lysosomal targets. We highlight how upstream regulatory pathways and post-translational modifications shape these substrate-specific outputs, and consider the implications of downstream uncoupling for the fundamental understanding of mTORC1 biology as well as human health and disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesTOR Serine-Threonine KinasesHumansAnimalsSubstrate SpecificityLysosomesProtein Processing, Post-TranslationalPhosphorylation

Substanzen

Mechanistic Target of Rapamycin Complex 1Multiprotein ComplexesTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Max Planck Institute for Biology of Ageing (MPI-AGE), 50931 Cologne, Germany.
  • Max Planck Institute for Biology of Ageing (MPI-AGE), 50931 Cologne, Germany; University of Cologne, Cologne Excellence Cluster for Aging and Aging-Associated Diseases (CECAD), 50931 Cologne, Germany.
  • Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK.
  • Max Planck Institute for Biology of Ageing (MPI-AGE), 50931 Cologne, Germany; University of Cologne, Cologne Excellence Cluster for Aging and Aging-Associated Diseases (CECAD), 50931 Cologne, Germany; European Research…

Förderung

  • Tenovus
  • H2020 European Research Council
  • Max Planck Society
  • Deutsche Forschungsgemeinschaft
  • Horizon 2020 Framework Programme
  • European Research Council
  • Horizon 2020

Zitieren

APA

Pan, J., Fernandes, S. A., Hatakeyama, R., & Demetriades, C. (2026). Substrate selectivity as a paradigm shift in mTORC1 signaling. Current Opinion in Cell Biology, 101, 102664. https://doi.org/10.1016/j.ceb.2026.102664

Vancouver

Pan J, Fernandes SA, Hatakeyama R, Demetriades C. Substrate selectivity as a paradigm shift in mTORC1 signaling. Current Opinion in Cell Biology. 2026;101:102664. doi:10.1016/j.ceb.2026.102664

BibTeX
@article{Pan2026,
  author = {Pan, Jiyoung and Fernandes, Stephanie A and Hatakeyama, Riko and Demetriades, Constantinos},
  title = {Substrate selectivity as a paradigm shift in mTORC1 signaling},
  journal = {Current Opinion in Cell Biology},
  year = {2026},
  volume = {101},
  pages = {102664},
  doi = {10.1016/j.ceb.2026.102664}
}
Kostenlos starten →